Pasar al contenido principal

DESCUBRIENDO LOS MECANISMOS MOLECULARES RESPONSABLES DEL INCREMENTO DE RIESGO DE ESQUIZOFRENIA INDUCIDO POR CANNABIS

PID2019-106404RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DEL PAIS VASCO EUSKAL HERRIKO UNIBERTSITATEA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

The role of the dopamine system in post-stroke mood disorders in newborn rats.

  • Villa, M
  • Martinez Vega, M
  • del Pozo, A
  • Muneta Arrate, I
  • Gómez Soria, A
  • Muguruza, C
  • de Hoz Rivera, M
  • Romero, A
  • Silva, L
  • Callado, L F
  • Casarejos, M J
  • Martínez Orgado, José Antonio
Post-stroke mood disorders (PSMD) affect disease prognosis in adults. Adult rodent models underlie the importance of the dopamine (DA) system in PSMD pathophysiology. There are no studies on PSMD after neonatal stroke. We induced neonatal stroke in 7-day-old (P7) rats by temporal left middle cerebral artery occlusion (MCAO). Performance in the tail suspension test (TST) at P14 and the forced swimming test (FST) and open field test (OFT) at P37 were studied to assess PSMD. DA neuron density in the ventral tegmental area, brain DA concentration and DA transporter (DAT) expression as well as D2 receptor (D2R) expression and G-protein functional coupling were also studied. MCAO animals revealed depressive-like symptoms at P14 associated with decreased DA concentration and reduced DA neuron population and DAT expression. At P37, MCAO rats showed hyperactive behavior associated with increased DA concentration, normalization of DA neuron density and decreased DAT expression. MCAO did not modify D2R expression but reduced D2R functionality at P37. MCAO-induced depressive-like symptoms were reversed by the DA reuptake inhibitor GBR-12909. In conclusion, MCAO in newborn rats induced depressive-like symptoms and hyperactive behavior in the medium and long term, respectively, that were associated with alterations in the DA system.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

  • Costas-Insua, Carlos
  • Moreno, Estefanía
  • Maroto, Irene B.
  • Ruiz-Calvo, Andrea
  • Bajo-Grañeras, Raquel
  • Martín-Gutiérrez, David
  • Diez-Alarcia, Rebeca
  • Vilaró, Maria Teresa
  • Cortés, Roser
  • García-Font, Nuria
  • Martín, Ricardo
  • Espina, Marc
  • Botta, Joaquín
  • Ginés, Silvia
  • McCormick, Peter J.
  • Sánchez-Prieto, José
  • Galve-Roperh, Ismael
  • Mengod Los Arcos, Guadalupe
  • Urigüen, Leyre
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Canela, Enric I.
  • Casadó, Vicent
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cannabinoids, the bioactive constituents of cannabis, exert a wide array of effects on the brain by engaging Type 1 cannabinoid receptor (CB1R). Accruing evidence supports that cannabinoid action relies on context-dependent factors, such as the biological characteristics of the target cell, suggesting that cell population-intrinsic molecular cues modulate CB1R-dependent signaling. Here, by using a yeast two-hybrid-based high-throughput screening, we identified BiP as a potential CB1R-interacting protein. We next found that CB1R and BiP interact specifically in vitro, and mapped the interaction site within the CB1R C-terminal (intracellular) domain and the BiP C-terminal (substrate-binding) domain-a. BiP selectively shaped agonist-evoked CB1R signaling by blocking an "alternative" Gq/11 protein-dependent signaling module while leaving the "classical" Gi/o protein-dependent inhibition of the cAMP pathway unaffected. In situ proximity ligation assays conducted on brain samples from various genetic mouse models of conditional loss or gain of CB1R expression allowed to map CB1R-BiP complexes selectively on terminals of GABAergic neurons. Behavioral studies using cannabinoid- treated male BiP1/2 mice supported that CB1R-BiP complexes modulate cannabinoid-evoked anxiety, one of the most frequent undesired effects of cannabis. Together, by identifying BiP as a CB1R-interacting protein that controls receptor function in a signaling pathway- and neuron population-selective manner, our findings may help to understand the striking context-dependent actions of cannabis in the brain., This work was supported by Spanish Ministerio de Ciencia e Innovación Grants RTI2018-095311-B-I00 to M.G., SAF-2017-87629-R to E.I.C. and V.C., PID2019-106404RB-I00 to L.U., BFU 2017-83292-R to J.S.-P., and RTI2018-094374-B-I00 to S.G.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas Grant PI2018/01 to M.G., S.G., and G. Mengod; and UK Research and Innovation Biotechnology and Biological Sciences Research Council Grant BB/R006946/1 to P.J.M., L.B., and G. Marsicano were supported by Institut National de la Santé et de la Recherche Médicale. C.C.-I. and I.B.M. were supported by contracts from Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). R.B.-G. was supported by a contract from Spanish Ministerio de Ciencia e Innovación Juan de la Cierva Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB 1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB 1 receptor (CB 1 R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB 1 R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB 1 R and impairs the CB 1 R-G i/o -cAMP-PKA pathway in a ubiquitin ligase- independent manner. Taken together, these findings unveil that CB 1 R overactivation is a driving mechanism of CRBN deficiency- linked ARNSID and anticipate that the antagonism of CB 1 R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB- I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Diez-Alarcia, Rebeca
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sanchez-Ruiz, A.
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-Iand IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, referencesFPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr.Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed